You were losing weight steadily, and then the scale just... stopped. For three weeks it hasn't moved. If that's where you are right now, the first thing to know is that this is normal, it happens to almost everyone on a GLP-1, and it almost never means the medication has stopped working. A plateau is a stage of the process, not the end of it. This guide explains why plateaus happen, how to tell a genuine plateau from ordinary day-to-day noise, and what actually helps you start moving again.
About the figures in this article
Quantitative outcomes referenced below are drawn from published clinical trials of FDA-approved Wegovy® (semaglutide; STEP 1, Novo Nordisk) and Zepbound® (tirzepatide; SURMOUNT-1, Eli Lilly). Those results were observed with the FDA-approved products studied in those trials and have not been clinically established for compounded medications. Individual outcomes vary; outcomes are not guaranteed; nothing in this article should be read as a prediction of how any specific patient will respond.
First: is it actually a plateau?
Most "plateaus" people panic about aren't plateaus at all — they're the normal, non-linear way the body sheds weight. Bodyweight swings several pounds in a single day based on water, sodium, carbohydrate intake, hormones, and what's still in your digestive tract. A single stuck week, or a week where you're up a pound, tells you almost nothing.
A real plateau is a trend that's flat. The working definition most clinicians use:
- No downward movement in your trend weight for at least 3–4 weeks, where trend weight means a rolling average of daily or near-daily weigh-ins — not one number on one morning.
- The same is true if your measurements and how your clothes fit haven't changed over that window either.
Before you change anything, confirm you're actually looking at a plateau and not at noise. The cleanest way to do that is to track a moving average rather than spot-checking the scale. The free Pallas companion app (Protein & GLP-1 Tracker, on iOS) graphs your weight trend, protein, and steps over time so a flat line — not a flat day — is what you react to. If the trend is still drifting down even slightly, you're not plateaued; you're just losing slowly, which is exactly what later-stage weight loss looks like.
Why plateaus happen
There's rarely a single cause. Usually it's a combination of the following.
1. You haven't reached your therapeutic dose yet
This is the most common and most fixable reason, especially in the first few months. GLP-1 medications are titrated upward slowly — 0.25 mg of semaglutide or 2.5 mg of tirzepatide is a starting dose meant to let your body adjust, not the dose that produces most of the weight loss. If the scale stalls while you're still on a low or mid-level dose, you may simply not be on enough medication yet. This is a conversation to have with your provider rather than something to fix with diet alone.
2. Metabolic adaptation
As you lose weight, you need fewer calories to run a smaller body — both because there's less of you to maintain and because the body defends against weight loss by modestly down-regulating energy expenditure (this is sometimes called adaptive thermogenesis). The calorie deficit that was melting weight off at the start shrinks as you get lighter, until intake and expenditure meet at a new equilibrium and the scale levels off. This is physiology working exactly as designed, not a personal failure — and it's why the rate of loss naturally slows the longer you're on therapy.
3. Muscle loss has lowered your metabolism
Any rapid weight loss — GLP-1 or not — costs you some lean muscle along with fat, and muscle is metabolically active tissue. Lose too much of it and your resting metabolic rate drops faster than it has to, which stalls the scale and worsens body composition. Without adequate protein and resistance training, a meaningful share of GLP-1 weight loss can come from lean mass. Protecting muscle is the single highest-leverage thing you can do during a plateau (more below).
4. Diet drift
Appetite suppression is strongest early on. As your body adapts to a stable dose, the "food noise" can creep back a little and portions quietly expand — an extra handful here, liquid calories there. None of it feels like overeating because it isn't, by old standards. But the deficit that drives loss is small at this stage, and small drift is enough to erase it. This is rarely about willpower; it's about the deficit getting narrower as you get lighter.
5. Water retention is masking real fat loss
Sometimes you are still losing fat, but the scale hides it. New or harder exercise, a high-sodium stretch, poor sleep, stress (cortisol), and hormonal cycles all cause the body to hold water, which can mask weeks of genuine fat loss. This is one more reason measurements, photos, and how clothes fit matter as much as the number on the scale.
6. You've reached a genuine dose ceiling
A smaller group of patients reach their maximum tolerated or maximum approved dose and find weight loss levels off there. Some respond beautifully at mid-level doses and hold; others reach the top and plateau above their goal. And a minority are non-responders — they tolerate the medication fine but never see much weight change. Distinguishing "needs more time," "needs a different lever," and "this molecule isn't working for me" is exactly what your provider is for.
What clinical trials tell us about the trajectory
Here's the reassuring part. In the pivotal trials of the FDA-approved products, weight loss didn't happen all at once and then stop — it continued, with a slowing curve, over a long horizon:
- STEP 1 (FDA-approved Wegovy®, semaglutide): average loss continued out to roughly 68 weeks, reaching about 15% of body weight on average.
- SURMOUNT-1 (FDA-approved Zepbound®, tirzepatide): average loss continued out to roughly 72 weeks, reaching about 20% on average.
Those results were observed with the FDA-approved products studied in those trials. They have not been clinically established for compounded medications, and individual outcomes vary by starting weight, dose, adherence, and lifestyle; outcomes are not guaranteed. The point for you isn't the headline number — it's the shape of the curve. Loss is fastest at the start and slows as you go. A flat stretch in month four or five is consistent with that trajectory, not a sign that something is broken.
What to actually do about it
Work through these in order. The first two matter most.
Talk to your provider before you change anything drastic
A plateau is a clinical data point, and the most common fix — a dose adjustment — is a clinical decision, not a DIY one. Your provider can tell whether you're stalled because you haven't titrated up yet, because you've hit a ceiling, or because something else is going on. Don't suffer in silence for two months or, worse, start skipping meals on your own. With Pallas, you can message your provider directly from the patient portal — no phone tag, no waiting room — and the same portal is where you'd request a refill or adjust your plan if your provider changes your prescription.
Protect your muscle: protein + resistance training
This is the highest-leverage lifestyle move during a plateau, because it attacks two causes at once — it slows the metabolic slowdown and it improves body composition even when the scale is stubborn.
- Hit a real protein target. A common evidence-based range is roughly 0.7–1.0 g of protein per pound of goal body weight per day. With appetite suppressed, most people drift toward easy carbs and undereat protein without realizing it — so this takes deliberate effort. Our protein calculator gives you a personalized number, and the companion app is built to track it day to day.
- Lift something twice a week. Even bodyweight resistance work 2–3× per week meaningfully preserves lean mass during fat loss. Cardio is good for you but doesn't protect muscle the way resistance training does.
Recheck your numbers
The deficit that worked at your starting weight is too big to still exist at your current weight. Recalculate your maintenance and target calories for the body you have now with our calorie / TDEE calculator, and don't drop below roughly 1,200 calories/day (women) or 1,500 (men) without your provider's guidance — under-eating backfires by accelerating muscle and metabolic loss. For a realistic sense of pace from here, the weight-loss projection tool can reset expectations.
Tighten the basics
- Protein and fiber first at every meal — they blunt the appetite rebound and keep digestion moving. See the best foods to eat on a GLP-1.
- Hydrate. You're eating less, so you're getting less water from food. Mild dehydration also amplifies GI side effects.
- Sleep and stress. Short sleep and chronic stress raise cortisol, drive hunger, and promote water retention. They're real plateau contributors, not background noise.
Ask whether switching the molecule makes sense
If you've genuinely reached a ceiling on semaglutide — adequate dose, protein and training dialed in, deficit verified — your provider may discuss switching to tirzepatide, which produced greater average loss in head-to-head data. This is strictly a provider-guided decision; the two are dosed differently and you'd restart titration. We cover the trade-offs in semaglutide vs tirzepatide.
Stalled and not sure why?
A licensed Pallas provider can review your dose, your trajectory, and your options — message them directly through the portal.
Start your intake →When the plateau is the point
Not every plateau is a problem to solve. Once you reach a weight you and your provider are happy with, the scale leveling off is the goal — that's maintenance, and most people stay on a GLP-1 long-term to hold it. The STEP 4 extension data showed that, on average, much of the lost weight returns within a year of stopping, which is why GLP-1 therapy is generally treated as ongoing, similar to medication for blood pressure. A maintenance plateau means the medication is doing its job. The work shifts from losing to protecting muscle and holding steady.
When to message your provider sooner rather than later
Reach out promptly — don't wait out the plateau — if:
- You've been stuck for 4+ weeks and you're still on a low or mid-level dose.
- You're losing weight but feel weak, are losing strength, or suspect you're shedding muscle.
- You're tempted to drastically cut calories or skip meals to force the scale down.
- Side effects have changed, or new symptoms (persistent pain, significant fatigue, mood changes, hair loss) have appeared.
- You've done everything right for two months and the scale genuinely hasn't moved — it may be time to reassess the dose or the molecule.
Frequently asked questions
Frequently asked questions
It varies. A short stall of one to three weeks is often just normal water and digestive fluctuation rather than a true plateau. A genuine plateau — no movement in your trend weight for four or more weeks — typically resolves once an underlying cause is addressed: a dose increase, a higher protein intake with resistance training, or correcting a deficit that shrank as you got lighter. There's no fixed duration; what matters is identifying which lever applies to you.
Usually one or more of: you haven't titrated up to your therapeutic dose yet; your body needs fewer calories now that it's smaller (metabolic adaptation); you've lost muscle, which lowers your metabolism; portions have quietly crept up as appetite suppression eased; or you're retaining water that's masking real fat loss. A smaller group reach a true dose ceiling. Your provider can help tell these apart.
Almost never. Weight loss naturally slows the longer you're on therapy — in the pivotal trials of the FDA-approved products, average loss continued for over a year but at a decreasing rate. A flat stretch in month four or five is consistent with that normal curve. The medication is still acting on appetite; the deficit driving the scale down has simply narrowed as you've gotten lighter.
Possibly — but that's a clinical decision for your provider, not something to do on your own. If you're stalled while still on a low or mid-level dose, not being at your therapeutic dose yet is the most common and most fixable cause. Message your provider; they'll decide whether a titration step, a longer hold, or a different approach is right for you.
A common evidence-based range is roughly 0.7 to 1.0 g of protein per pound of your goal body weight per day, paired with resistance training two to three times a week. This protects lean muscle, which slows the metabolic adaptation that stalls the scale and improves body composition even when the number isn't moving. Because appetite is suppressed, most people undereat protein without realizing it, so hitting the target takes deliberate effort.
Maybe, if you've genuinely reached a ceiling — adequate dose, protein and training dialed in, and your deficit verified — and you and your provider agree. Tirzepatide produced greater average weight loss than semaglutide in head-to-head data. But switching means restarting titration on a differently dosed medication, so it's strictly a provider-guided decision rather than a first response to a stall.
Bottom line: A stalled scale is almost always a stage, not a wall. Confirm it's a real plateau by watching your trend rather than a single morning, protect your muscle with protein and resistance training, recheck the deficit for your current weight, and loop in your provider about your dose before making drastic changes on your own. Most plateaus break with a small adjustment and a little patience — and the ones that don't are exactly the conversation your provider is there to have.
Ready to see if you qualify?
A licensed Pallas provider can review your health history and confirm eligibility in under 2 minutes.
Start your intake →